Clinical Trial
APS001: Effectiveness of the Autism Pupil Screen (APS) Detect Pupillometer for Identifying Autism Spectrum Disorder (ASD) in Routine Healthcare
Learn about a clinical trial examining the safety and effectiveness of an investigational device designed to help healthcare professionals identify ASD in children.This study is an FDA clinical trial sponsored by Schweitzer Engineering Laboratories, Inc. (SEL). The trial will examine the safety and effectiveness of an investigational device designed to help healthcare professionals screen for ASD in children ages two to five years old in routine healthcare settings. This clinical trial uses an investigational pupillometer device that measures a child’s pupillary light reflex (PLR) and compares the data against typical and atypical development. This device is not yet cleared for safety and effectiveness by the FDA. The trial is being conducted at outpatient pediatric and family medicine clinics in the Inland Northwest.Learn more about the trial at clinicaltrials.gov.
Interested in joining the trial?
For more information, please contact the SEL clinical research coordinator at clinicaltrials@selinc.com or 509.334.8800.Clinical Trial Primary Investigators:
Georgina Lynch, PhDKeith Gautreaux, MD
Kathryn Hryniewicz, MD
Sterling McPherson, PhD
Locations
The clinical trial takes place at the following locations:
FAQ
Questions About Clinical Trials and How to Participate
This study has been approved for human subject participation by the Washington State University Institutional Review Board, IRB Approved Protocol # [TBD] Read and download the study flyer here.